Mark Lawler

11.7k citations
308 papers · 8.9k · 2 hit papers · h-index 49

Impact in

  • Hematology top 0.5%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Oncology top 1%
    • COVID-19 and healthcare impacts
    • Colorectal Cancer Treatments and Studies

Papers in

    • Hematopoietic Stem Cell Transplantation 36
    • Chronic Myeloid Leukemia Treatments 18
    • Global Cancer Incidence and Screening 20
    • Colorectal Cancer Treatments and Studies 19

Mark Lawler

302 papers receiving 8.6k citations

Mark Lawler's Hit Papers

Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study 2020 · 374 citations
3740+2+4Years since publication100200300

Peers

Mark Lawler
Comparison fields: 5 of 171
  • Hematology 1.5k
  • Oncology 2.4k
  • Cancer Research 1.1k
  • Genetics 506
  • Pathology and Forensic Medicine 719
Replace William S. Dalton with:
William S. Dalton United States
Gilles Vassal France
Asim Ijaz Khwaja United Kingdom
Amanda L. Blackford United States
Ann T. Farrell United States
Rajeshwari Sridhara United States
Eva C. Guinan United States
Christian Chabannon France
John Raymond Zalcberg Australia
Serge Leyvraz Switzerland
Mark Lawler relative to William S. Dalton United States William S. Dalton's profile →
Citations per field
00.5×2×4×5.2×
William S. Dalton · 1×
Citations per year

Countries citing papers authored by Mark Lawler

Since Specialization
Citations

This map shows the geographic impact of Mark Lawler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lawler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lawler more than expected).

Fields of papers citing papers by Mark Lawler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lawler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lawler. The network helps show where Mark Lawler may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Lawler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Lawler Line = papers co-authored together Mark Lawler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
Hit paper breakdown →
2020374
2
Integrating Genomics into Healthcare: A Global Responsibility
Hit paper breakdown →
2019315
3 2020231
4 1989203
5 2000196
6 2017178
7 2018163
8 1991151
9 2016130
10 2003129
11 2005125
12 2009121
13
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.
2000120
14 2020115
15 2019115
16 2010114
17 1990109
18 2018106
19 2008102
20 2018102

About Mark Lawler

Mark Lawler is a scholar working on Hematology, Oncology, Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 308 papers that have together received 8.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (36 papers), Economic and Financial Impacts of Cancer (28 papers), Cancer Genomics and Diagnostics (27 papers), Global Cancer Incidence and Screening (20 papers), Genetic factors in colorectal cancer (20 papers), Colorectal Cancer Treatments and Studies (19 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Chronic Myeloid Leukemia Treatments (18 papers). The work is most often cited by research in Hematology (1.5k citations), Oncology (2.4k citations), Cancer Research (1.1k citations), Genetics (506 citations) and Pathology and Forensic Medicine (719 citations). Mark Lawler has collaborated with scholars based in United Kingdom, Ireland and United States. Frequent co-authors include Donal P. Hollywood, Peter Humphries, SR McCann, Shaun R. McCann, Antoinette Sabrina Perry, Richard Sullivan, Laure Marignol, Patrick G. Johnston, Mary A. Coffey and Sandra Van Schaeybroeck. Their work appears in journals such as The Lancet Oncology, British Journal of Haematology, Journal of Cancer Policy, Bone Marrow Transplantation and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact